Maarssen, Netherlands, Netherlands · Est. 1911
Solvay Pharmaceuticals was a pharmaceutical company focused on neurology, psychiatry, and respiratory treatments that was acquired by Abbott Laboratories in 2010.
Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Therapeutic Focus
Recent SEC Filings
8-K
8-K
8-K
Regulatory
Lithobid — LITHOBID
Application NDA018027
Lithobid — LITHOBID
Application NDA018027
Lithobid — LITHOBID
Application NDA018027
Lithobid — LITHOBID
Application NDA018027
Lithobid — LITHOBID
Application NDA018027
Lithobid — LITHOBID
Application NDA018027
Lithobid — LITHOBID
Application NDA018027
Lithobid — LITHOBID
Application NDA018027
Luvox — LUVOX
Application NDA021519 (NDA)
Luvox Cr — LUVOX
Application NDA021519 (NDA)
Luvox — LUVOX CR
Application NDA022033 (NDA)
Luvox Cr — LUVOX CR
Application NDA022033 (NDA)
Lithobid — LITHOBID
Application NDA018027
Lithobid — LITHOBID
Application NDA018027
Lithobid — LITHOBID
Application NDA018027
Lithobid — LITHOBID
Application NDA018027
Lithobid — LITHOBID
Application NDA018027
Lithobid — LITHOBID
Application NDA018027
Lithobid — LITHOBID
Application NDA018027
Lithobid — LITHOBID
Application NDA018027
8-K
Accession: 0001628280-26-070119
8-K
Accession: 0001865107-26-000043
8-K
Accession: 0001865107-26-000037
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)